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a b s t r a c t
Endogenous retroviruses (ERVs) were acquired during evolution of their host organisms after infection
and mendelian inheritance in the germline by their exogenous counterparts. The ERVs can spread in the
host genome and in some cases they affect the host phenotype. The cervid endogenous gammaretrovirus
(CrERV) is one of only a few well-deﬁned examples of evolutionarily recent invasion of mammalian
genome by retroviruses. Thousands of insertionally polymorphic CrERV integration sites have been
detected in wild ranging mule deer (Odocoileus hemionus) host populations. Here, we describe for the
ﬁrst time induction of replication competent CrERV by cocultivation of deer and human cells. We
characterize the physical properties and tropism of the induced virus. The genomic sequence of the
induced virus is phylogenetically related to the evolutionarily young endogenous CrERVs described so
far. We also describe the level of replication block of CrERV on deer cells and its capacity to establish
superinfection interference.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Endogenous retrovirus sequences constitute an integral part of
all vertebrate genomes. They are generated following infection of
the germline lineage of the host by an exogenous retrovirus and
subsequent vertical inheritance of the integrated provirus form
(Feschotte and Gilbert, 2012). The ERVs are classiﬁed into a large
number of groups, whose diversity exceeds the currently circulat-
ing retrovirus species (Blomberg et al., 2009; Hayward et al., 2015).
After the initial establishment of an integrated virus copy, which
serves as a founder for a speciﬁc ERV group, further ampliﬁcation
and creation of new copies is enabled either by reinfection or by
intracellular retrotransposition in the germline (Dewannieux et al.,
2004; Jern and Cofﬁn, 2008; Kanda et al., 2013).
Uncontrolled proliferation of ERVs in the genome would cause
a burden for the host through mutagenic and various other effects.
Therefore, there are multiple mechanisms that keep ERV expres-
sion and replication under control, most notably by transcriptional
silencing (Liu et al., 2014; Rowe and Trono, 2011; Turelli et al.,
2014). On the other hand, ERVs can be utilized for protection of the
host from infecting retroviruses, a concept dubbed as “ﬁghting ﬁre
with ﬁre” (Malfavon-Borja and Feschotte, 2015). There are several
well-documented cases in chickens, mice, cats and sheep, where
endogenous envelope (Env) proteins can prevent the cell surface
receptors from interacting with incoming retrovirus, resulting in a
block of cellular entry (Malfavon-Borja and Feschotte, 2015). ERV-
encoded proteins can also cause inhibition at several post-entry
stages of infection (Arnaud et al., 2007b; Best et al., 1996; Monde
et al., 2012). Another important way how ERVs can inﬂuence the
outcome of retroviral infection is through recombination. ERV
genomes can recombine among different endogenous loci or with
related exogenous retroviruses. This can lead to the generation of
fully infectious virus from two defective ERV genomes, or to the
altered properties, for example altered tropism, of the exogenous
partner involved in the recombination (Anai et al., 2012; Levy,
2008; Paprotka et al., 2011; Shimode et al., 2015; Young et al.,
2012). In addition, through recombination with cellular genes,
ERVs can form acutely transforming retroviruses (Kozak, 2015).
A practical classiﬁcation is to consider ERVs as either “ancient”
or “modern”, based on the time when they inﬁltrated the host
genome (Armezzani et al., 2014). Most ERVs belong to the ancient
category, where the genome invasion occurred long time ago in
the evolutionary history of the host species, usually before the last
speciation. Consequently, the individual ERV integrations are ﬁxed
in the host population, or even shared in phylogenetically related
species. Modern ERVs entered the host genome more recently,
mostly after speciation. Such ERV integrations have typically not
yet reached ﬁxation or been lost from the host lineage. At that
stage, they are present in some individuals and absent in others,
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which is denoted as insertional polymorphism. There are only a
few well-studied examples of modern ERVs, these include the
koala retrovirus (KoRV), endogenous Jaagsiekte sheep retroviruses
(enJSRVs), porcine endogenous retroviruses (PERVs), endogenous
feline leukemia viruses (enFeLVs) and other feline endogenous
retroviruses (ERV-DCs), various mouse ERVs, and cervid endogen-
ous gammaretrovirus (CrERV). The research on these viruses has
lead to important insights into the process of genome invasion by
an ERV and of the changes that accompany endogenization (Anai
et al., 2012; Arnaud et al., 2007a; Lavillette and Kabat, 2004; Li
et al., 2012; Oliveira et al., 2007; Tarlinton et al., 2006). In koalas,
sheep and cats and mice, exogenous counterparts of the respective
ERVs are circulating in natural populations and are associated with
disease (Armezzani et al., 2014; Kozak, 2015; Levy, 2008; Xu et al.,
2015). Replication-competent variants of PERV have also been
reported (Preuss et al., 2006). In our previous studies we have
advanced knowledge of the CrERV-mule deer model (Bao et al.,
2014; Elleder et al., 2012; Kamath et al., 2014; Wittekindt et al.,
2010). We have described an extensive collection of thousands of
polymorphic endogenous retrovirus integration sites, comprehen-
sively documenting the recent invasion of mule deer genomes by
CrERV. The integration site patterns in individual deer were
analyzed and revealed ﬁne population structure and history of
wild mule deer populations, with better resolution than in a
parallel analysis performed with microsatellite markers (Kamath
et al., 2014). However, all our previous work was focused on
analysis of the integrated CrERV DNA or of the viral RNA expres-
sion. We have never obtained conclusive evidence of virus pro-
duction or replication. Therefore, we attempted to replicate a
previously published experiment (Aaronson et al., 1976), where
primary blacktail deer (O. hemionus colubmianus, a subspecies of
mule deer) cells were cocultured with human cell line. This led to
the induction of replication competent gammaretrovirus species of
hitherto unknown sequence, denoted deer kidney virus (DKV)
(Aaronson et al., 1976; Barbacid et al., 1980).
In this study we report a successful induction of replication-
competent CrERV from coculture of deer cells with a susceptible
human cell line. We have characterized the physical properties of
the induced virus, its phylogenetic relatedness to known endo-
genous CrERV copies, and its infectivity on deer and human cells.
We also analyzed the capacity of the induced virus to establish
interference to superinfection.
Results
CrERV can be induced by coculture of deer and human cells
Black-tailed deer primary kidney cells (OHK) and a human rhabdo-
myosarcoma cell line A673 were used in the coculture experiment.
These cells were the same as those used in the original protocol
(Aaronson et al., 1976). After approximately 30 days, RT activity in
culture medium could be detected by a sensitive product-enhanced RT
(PERT) assay (Fig. 1). At this point we stopped adding the OHK cells,
which had served as a source of the induced virus. Due to much faster
growth, only the human cells remained presumably in the subsequent
continuation of the coculture. The RT activity continued to increase and
eventually reached a plateau. The resulting RT level was still very low,
approximately a thousand times lower than the values obtained for
another endogenous gammaretrovirus, PERV (porcine endogenous
retrovirus). The human and deer cells cultured separately tested
negative in the PERT assay (data not shown). To conﬁrm the identity
of the induced virus species, viral cDNA was prepared from
ultracentrifugation-concentrated culture ﬂuids. Sequences highly iden-
tical to CrERV were obtained (full sequence of induced CrERV [CrERV-
IND] is reported below). Therefore it is highly probable that DKV
described by Aaronson, from which no sequence data is available, is
identical to our recently reported CrERV.
CrERV particles
Next we examined whether the RT activity obtained from the
coculture experiment belonged to particles of expected retrovirus
buoyant density. The pelleted CrERV-IND was separated on iodixanol
gradient and individual gradient fractions were tested by the PERT assay.
For comparison we used virus particles of well-described endogenous
gammaretrovirus, PERV (Bartosch et al., 2004). The RT activity peaked
around the expected density of 1.1 g/ml, typical for retrovirus particles
(Contreras-Galindo et al., 2012) (Fig 2A). We also obtained electron
micrographs of both CrERV-IND and PERV (Fig. 2B).
The induced CrERV is infectious and xenotropic
Then, we evaluated the infectivity of the CrERV-IND particles.
The virus inoculum from the coculture was used to infect naïve
human and deer cells, and infectivity was assessed by the
appearance of RT activity in the culture medium. Both human
A673 and HEK 293 T cells could be infected (Fig. 4), however no RT
activity was detected upon infection of deer OHK cells (data not
shown). This is consistent with xenotropic characteristics of the
induced virus, and is in agreement with observations reported by
Aaronson et al. (1976) for DKV.
Relationship of induced CrERV sequence with known endogenous
proviruses and construction of infectious molecular clone
To obtain the full sequence of CrERV-IND, we have ampliﬁed
the provirus DNA from CrERV-infected HEK 293 T cells by long-
range PCR. This sequence (deposited in Genbank under accession
number KP261824) was 9,027 nucleotides long and had high
identity across the entire length with a previously reported
complete provirus genome, denoted CrERV-in7 (Elleder et al.,
2012). There were intact open reading frames for all viral genes,
gag, pro/pol, and env (Fig. 3B). We performed phylogenetic com-
parison of CrERV-IND with a set of previously published twelve
endogenous CrERVs (Kamath et al., 2014). Because the full
sequences of these CrERVs are not known, we have used an
alignment of approximately 1.1 kb region in the 3'end of the virus
genome to create the phylogeny. This region was identiﬁed
Fig. 1. Induction of virus from O. hemionus primary kidney cells cocultivated with
human rhabdomyosarcoma cell line. At the indicated times, the RT activity in the
culture supernatants was measured by a sensitive PERT assay. The results are
expressed as means and standard deviations from triplicate assays.
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previously (Kamath et al., 2014) to be convenient for phylogenetic
analysis because it minimizes the inﬂuence of recombinant
sequences. The CrERV-IND sequence clustered with good support
with the large group of insertionally polymorphic, evolutionarily
young CrERVs (Fig. 3 A). The CrERV-in1, which represents an
evolutionarily old integration, was located on a separate branch.
We further compared the CrERV-IND sequence with four
CrERVs for which we have full genomes available. Consistent with
the results from the phylogenetic tree, the closest sequence to
CrERV-IND was CrERV-in8, with only 24 genetic changes scattered
over the entire 9- kb genome (Fig. 3B). CrERV-in4 and CrERV-in7
had 26 and 41 changes, respectively, relative to the CrERV-IND,
and CrERV-in5 was even more distant. The ratio of nonsynon-
ymous to synonymous substitutions in the coding regions was
always higher in env than in gag and pro/pol (Fig. 3B). This is
consistent with a higher degree of purifying selection in gag and
pro/pol than in the env gene.
To standardize the work with the CrERV-IND, a molecular clone
was constructed by subcloning the long range PCR product into
pGEM-T Easy plasmid vector. The resulting construct pCrERV-IND
was replication competent following transfection into HEK 293 T
cells and subsequent infection of naïve cells. All subseq-
uent analyses were performed with virus derived from this
molecular clone.
CrERV infection kinetics in human cells
The RT activity of the CrERV-IND was very low even on
permissive human cells. This is caused at least in part by very low
titer of the virus. In end-point dilution experiments, the CrERV
infectious titer on HEK 293 T cells was 102–3 per ml. In addition, we
tried to evaluate the infection kinetics using quantitative PCR
methods. PERV was used again for comparison, and both viral
inocula were normalized for RT activity. We have used both standard
SYBR green real-time quantitative PCR and a highly sensitive digital
droplet PCR method. The assay was detecting the newly formed
virus DNA in the env gene region, corresponding to intermediate
products of reverse transcription. The products could be detected
several hours after infection of human cells and peaked around 8–
24 h p.i., as described for other retroviruses (Mohammadi et al.,
2013) (Fig. 4, left). The levels of newly made CrERV DNA were very
low, about hundred times lower than for PERV. Based on the peak
values being below 1x103 CrERV DNA copies per diploid cell
genome, we estimate that less that 1 in 1000 cells was infected.
However, during long-term culture of infected HEK 293 T cells,
presumably all cells become infected in the course of about 3 weeks,
because the virus DNA level reaches a plateau with values close to
one copy per diploid cell genome (Fig. 4, right).
Early block of CrERV infection on deer cells, caused presumably by
receptor interference
The induced CrERV was unable to productively infect deer cells
and we wanted to characterize the level of the putative replication
block. PCR-based assays used for human cells were not applicable
because of the large background of hundreds of endogenous CrERV
copies (Elleder et al., 2012) that would co-amplify together with the
newly formed virus DNA in deer cells. Other relevant approaches,
namely CrERV ENV pseudotypes of MLV and marker rescue assays
were technically unsuccessful even after repeated attempts. There-
fore, we used an alternative approach and by in vitro mutagenesis
of the CrERV-IND molecular clone, we generated a sequence variant
CrERV-mut. This construct contained several silent mutations in the
pol gene (Fig. 5A). We have selected nucleotide variants not present
in any of the previously described CrERV endogenous copies
(Elleder et al., 2012; Kamath et al., 2014). This allowed us to design
PCR primers that ampliﬁed only the newly generated CrERVmut
DNA and not any of the endogenous CrERV copies or the parental
CrERV virus (Fig. 5B, lanes 7 and 8). CrERV-mut virus was infectious,
because it could infect naïve HEK-293 T cells (Fig. 5B, lanes 5 and 6).
However, CrERV-mut newly made viral DNA was not detectable
upon infection of deer cells (Fig. 5B, lanes 1 and 2). Therefore, either
Fig. 2. Characterization of CrERV particles. (A) Pellets containing ultracentrifugation-concentrated virus particles were resuspended in PBS and layered on top of 10–50%
stepwise iodixanol gradients. Following 17 h of centrifugation at 209,000 g, aliquots from each fraction were tested for RT activity by the PERT assay. Averages and standard
deviations from triplicate assays are shown as black circles. Density of individual gradient fractions is depicted by gray triangles, with values displayed on the right axis.
(B) Electron micrographs of retrovirus particles obtained by negative staining are shown, with 100 nm scale bar highlighted. In both A and B, CrERV is positioned on the left
and PERV on the right.
H. Fábryová et al. / Virology 485 (2015) 96–10398
receptor-mediated entry or some of the earliest steps of CrERV
replication (virus uncoating, RT initiation), that precede virus DNA
synthesis, are deﬁcient in deer cells. To further test if receptor
interference can block CrERV infection, we used the human cells
chronically infected with CrERV. These cells presumably all harbor
integrated CrERV (Fig. 4B) and express the virus envelope and
therefore have the capacity to block cellular receptors used for virus
entry. The chronically infected cells did not support generation of
CrERVmut virus DNA (Fig. 5B, lanes 3 and 4) This is consistent with
receptor interference being the cause of the resistance to CrERV on
both deer cells and chronically infected human cells.
Discussion
Here we report the induction and characterization of a replication
competent endogenous gammaretrovirus, CrERV, from mule deer
cells in a coculture experiment. The process that led to the induction
of CrERV production from the coculture is not known. It could have
involved low production of infectious virus particles from deer cells,
which then infected the permissive human cells. We have not
detected virus production from deer cells by the PERT assay. However,
this production could have been extremely low or intermittent.
Among other potential mechanisms are rare spontaneous cell fusion
Fig. 3. Relationships between CrERV-IND sequence and endogenous CrERVs. (A) Phylogenetic tree generated from alignment of 1.1 kb region in the 30end of the CrERV-IND
and endogenous CrERVs. CrERV-IND position is highlighted by an open box. Bootstrap supports higher than 0.7 are indicated at the tree nodes. The branch length is
proportional to the number of substitutions per site, with scale bar shown below the tree. (B) Comparison of the CrERV-IND sequence with four full endogenous CrERV
genomes. The CrERV-IND genome is shown as a schematic at the top. Virus genes and LTRs are shown as shaded boxes and two direct 55- bp repeats in the leader region are
displayed as small ovals. Every genome is depicted by horizontal black line, ﬂanked with short target site duplication (TSD) sequences that arise during retrovirus integration.
Short vertical lines indicate single nucleotide mismatches relative to the CrERV-IND sequence. Mismatches inside the coding regions for gag, pro/pol and env are shown above
and below the horizontal line for the changes that result in nonsynonymous and synonymous substitutions, respectively, in the corresponding virus ORF. The numbers above
each line represent the number of nonsynonymous: number of synonymous substitutions in each gene. The percentage of nonsynonymous mutations out of total mutations
is shown in parentheses. Upward pointing black triangles indicate single nucleotide insertions, downward pointing triangles are single nucleotide deletions (the sign 3x
denotes three closely spaced deletions). Open triangles represent insertion of third 55- bp direct repeat in the leader region. Premature stop codons are indicated by asterisk.
Gray shaded box shows a region of CrERV-in5 env gene that is unalignable with CrERV-IND env. V-shaped line indicate region with large deletion.
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events, direct cell-to-cell transmission through virological synapses,
or even transfer via exosomes (Sattentau, 2010; Wurdinger et al.,
2012). In general, virus transmission or rescue by cocultivation was
proven to be the most effective method for both endogenous and
exogenous retroviruses (Agosto et al., 2015; Patience et al., 1997;
Svoboda et al., 1963; Xu et al., 2013).
Several lines of evidence show that the induced CrERV is
identical to the previously reported DKV, although the DKV
genome has never been sequenced by the Aaronson laboratory.
First, we tried to reproduce the setting of the original experiment,
most importantly we used the same cell types in the coculture.
Second, immunological methods established that DKV belonged to
gammaretroviruses (Aaronson et al., 1976; Barbacid et al., 1980), as
does CrERV. Third, DNA hybridization techniques using DKV
probes established the presence of closely related endogenous
viruses in all tested cervid species (Tronick et al., 1977). More
Fig. 4. CrERV infection kinetics on HEK 293 T cells. (Left) Quantiﬁcation of newly made virus DNA in the ﬁrst two days post infection. At indicated times, infected cells were
collected and cellular lysates were prepared as described in Methods. Real-time PCR assays using MESA green and primers complementary to the virus env were used to
quantify virus DNA levels. CrERV is depicted by black circles and PERV by gray triangles. (Right) Long-term infection of HEK 293 T cells by CrERV. Virus DNA levels in cellular
lysates were quantiﬁed by digital droplet PCR method, using the same env-based primers as in the experiment depicted on the left diagram. The resulting values are shown
as black circles. RT activity was determined from culture supernatants in parallel and is shown as gray triangles. The infection experiments were performed at least twice
with similar results. Values from one representative experiment are shown, with averages and standard deviations from quantitative assays performed in triplicate.
Fig. 5. Infection of human and deer cells by a CrERV sequence variant generated by in vitro mutagenesis, CrERV-mut. (A) A schematic depicting position and sequence of the
primer pairs that speciﬁcally detect only CrERV-IND or CrERV-mut DNA. The upper and lower sequences represent the CrERV-IND and CrERV-mut genome, respectively. The
nucleotide substitutions generated in CrERV-mut are underlined and bold. The arrows indicate positions of primers. Primers WT-fw and WT-rv amplify only the CrERV-IND
virus DNA. Primers mut-fw and mut-rv amplify speciﬁcally the CrERV-mut DNA. (B) CrERV-mut was used to infect deer OHK cells (lane 1), HEK 293 T cells (lane 5) and HEK
293 T cells chronically infected with CrERV-IND (lane 3). Heat-inactivated (h.i.) virus was used in each case as a negative control to exclude virus DNA contamination (lanes 2,
4, and 6). Cells were harvested 20 h after infection and cellular lysates were prepared as described in Methods. CrERV-mut (lane 7) and CrERV-IND (lane 8) plasmid DNA was
used as a control for speciﬁcity of PCR ampliﬁcation. The upper panel shows PCR products generated with primers mut-fw and mut-rv, which detect speciﬁcally the CrERV-
mut DNA. The lower panel shows PCR products generated with primers WT-fw and WT-rv. These primers amplify the “wild-type” variants of CrERV, i.e. the endogenous
CrERVs in deer cells (lanes 1 and 2), and CrERV-IND in chronically infected 293 T cells (lanes 3 and 4). The experiments were performed twice with identical results; one
representative experiment is displayed. M, molecular size marker; NTC, non-template control.
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distantly related endogenous retroviruses were detected in other
artiodactyls, e.g. in sheep. This pattern of distribution is consistent
with the detection of various CrERV-related sequences in mam-
malian genomes (Elleder et al., 2012). A last argument pointing to
the identity between CrERV and DKV is the similar tropism of both
viruses, discussed below. DKV was shown to replicate on human
cells but not deer cells, same as CrERV. In addition, DKV had a
narrow xenotropic host range; it could replicate on horse cells, but
not in cells of several additional mammalian species (Aaronson
et al., 1976).
The genomic sequence of CrERV-IND did not show any appar-
ent defect; it had complete open reading frames for all viral genes.
In addition, the construction of an infectious molecular clone
excluded the theoretical possibility that a helper virus from deer
cells was needed for the replication of CrERV-IND. The obtained
sequence was closest to the group of evolutionarily young and
highly insertionally polymorphic CrERVs. This is consistent with
the assumption that the youngest ERVs retain the highest capacity
to be mobilized to form infectious progeny. Indeed, the closest
relative to CrERV-IND was CrERV-in8, which was extremely rare in
the population study, with only 1 positive animal out of 262 total
(Kamath et al., 2014). However, none of the endogenous CrERVs
was completely identical to CrERV-IND, therefore we cannot
determine the source element that gave rise to the induced virus.
There are hundreds of endogenous CrERVs in each deer genome;
moreover, the deer cells used in the coculture were different from
those we analyzed previously. We cannot exclude that recombina-
tion events between several endogenous CrERVs were involved in
the generation of CrERV-IND, similar scenario was described for
several other ERVs (Anai et al., 2012; Levy, 2008; Shimode et al.,
2015; Young et al., 2012). Interestingly, although we analyzed only
a few CrERV genomes, there seems to be a trend towards higher
degree of purifying selection in gag and pro/pol than in env. Loss of
env has been identiﬁed as a factor determining greater expansion
of ERVs within the genome (Magiorkinis et al., 2012).
The buoyant density of CrERV-IND and electron micrographs of
virus particles did not show obvious aberrations. However, the
infectivity of CrERV-IND was very low even on permissive human
cells. This could be due either to inherent defect of the CrERV-IND
genome or to low permissivity of the human cells. The early
kinetics of virus DNA production seemed normal and the virus
eventually infected presumably all cells in the culture.
To explain the xenotropic nature of CrERV-IND, we tried to
determine the level of the replication block on deer cells. Using the
genetically modiﬁed variant CrERV-mut, we have shown that the
block occurred before the viral DNA synthesis. The most plausible
explanation is the receptor interference caused by the expression
of endogenous env genes. To support this explanation, we have
further shown that CrERV has the capacity to establish super-
infection resistance on chronically infected human cells. However,
because the cellular receptor for CrERV is not known, we cannot
exclude that it is mutated in deer. Selection for such mutations in
receptors for ERVs has been documented in endogenous avian
leukosis viruses (ALV) and murine leukemia viruses (MLVs)
(Barnard et al., 2006; Kozak, 2015). Treatment with tunicamycin,
inhibitor of N-linked glycosylation, has been shown in some cases
to abrogate resistance to retrovirus entry, by deglycosylation of the
cellular receptors or the virus envelope proteins (Koo et al., 1994;
Miller and Miller, 1992). However, tunicamycin treatment did not
rescue sensitivity to CrERV upon infection of either deer cells or
the chronically infected human cells (data not shown).
There is an intriguing paradox between the xenotropic nature
of CrERV and its high efﬁciency of generation of new germline
integrations in mule deer lineage in recent past. One possible
solution to this paradox is that endogenous CrERVs are not
expressed in the germline cells and therefore do not block the
entry receptors. Alternatively, more variants of CrERV may exist
that differ in receptor usage and can overcome the interference
blocks, a mechanism described in FeLV and KoRV (Overbaugh
et al., 2001; Xu et al., 2015). Even more complex mechanism was
described in PERVs, where disruption of a highly conserved PHQ
motif in the envelope glycoprotein enables transactivation of such
viruses by unrelated gammaretroviral envelopes (Lavillette and
Kabat, 2004). The PERVs with disrupted PHQ motif gain the ability
to infect cells that lack the cognate PERV receptors and also to
overcome restrictions caused by receptor interference. This prop-
erty was suggested to provide novel opportunities to infect germ
cells (Lavillette and Kabat, 2004). Interestingly, we observe a
tendency toward disruption of the PHQ motif in the evolutionarily
young CrERVs (D.E., personal communication). The analysis of the
possible underlying mechanisms is under way in our laboratory.
Materials and methods
Cells and co-cultivation protocol
Human rhabdomyosarcoma cell line A-673 (ATCC product
number CRL-1598) and primary O. hemionus kidney cells (OHK,
ATCC product number CRL-6193) were grown in Dulbecco's
modiﬁed Eagle's medium (Sigma-Aldrich, St. Louis, MO) supple-
mented with 10% fetal calf serum, penicillin and streptomycin.
HEK 293 T cells were grown in the same conditions, with serum
supplements changed to 4% fetal calf serum and 4% calf serum.
HEK-293 T cells producing PERV 14/220 (Bartosch et al., 2004)
were used as a source of porcine gammaretroviral particles. All
cells were cultured in a humidiﬁed incubator at 37 1C and 5% CO2.
The co-cultivation experiment was started by mixing equal num-
bers of deer CRL-6193 and human A-673 cells. Every week, fresh
cells from both species were added to the coculture at 1:1 ratio. At
indicated time points, samples of the culture ﬂuids were harvested
for the RT assay. The samples were spun at 3000 RPM for 5 min to
remove cell debris, ﬁltered by a 0.22 μm syringe ﬁlter and frozen at
80 1C before further use.
PERT assay
The PERT assay was adapted from previously published proto-
cols (Lovatt et al., 1999; Pizzato et al., 2009; Sears and Khan, 2003).
The samples (2 ml of culture supernatant or gradient fraction) were
lysed in 8 mL of solution containing 1% TRITON X-100, 0.4 U/mL
RNasin (Promega), and 1x ProtoscriptII buffer (New England
Biolabs) at room temperature for 30 min. Then, two master-
mixes (A and B) were prepared, with the following amounts per
one reaction: Mix A contained 20 ng of the template RNA of MS2
phage (Roche), 0.5 ul of the reverse primer (50- GCCTTAG-
CAGTGCCCTGTCT) and 10.1 ul water. Mix B contained 3.6 ul of 5x
ProtoscriptII buffer, 2 ul of 100 mM DTT, 0.8 ul of 10 mM dNTP2,
and 6.4 ul water. Mix A was incubated at 65 1C for 5 min and
slowly cooled down to allow primer annealing. Next the mixes A
and B were pooled and aliqoted by 18 ul. To each aliquot, 2 ul of
the lysates were added and incubated at 37 1C for 30 min (reverse
transcription step), then inactivated at 70 1C for 10 min, The newly
generated MS2 cDNA was quantiﬁed by real-time PCR assay with
forward (50- AACATGCTCGAGGGCCTTA) and reverse primers and
probe (FAM-TGGGATGCTCCTACATG-TAMRA). Each reaction con-
tained 1.5 ul of the cDNA sample, 1xqPCR master mix (Eurogentec,
Seraing, Belgium), 7.5 pmol of each primer and 3.75 pmol of probe
in a total volume of 15 ul. The samples were run on a Bio-Rad
CFX96TM Real-Time instrument with a three-step protocol: 1 cycle
of 10 min at 95 1C and then 45 cycles consisting of 15 s at 95 1C,
20 s at 60 1C and 20 s at 72 1C. Cycles of quantiﬁcation (Cq) values
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were generated by the CFX Manager software. With each run, one
calibrator sample was assayed and all values were expressed as
relative values compared to the calibrator.
Iodixanol gradient
Iodixanol (OptiPrep™) was purchased from Axis Shield (Dundee,
United Kingdom). Thirty milliliters of cell free supernatants from
virus-producing cells were cleared from cellular debris by low-speed
centrifugation (3000 RPM for 5 min at 4 1C) and then centrifuged
through a 20% iodixanol cushion in a SW28 rotor (Beckman Coulter
Pasadena, CA) for 2 h at 23,000 RPM. The centrifuged pellet was
resuspended in 1 ml of PBS. Two-milliliter layers containing 50%, 40%,
30%, 20%, and 10% iodixanol were pipetted in tubes for the SW41Ti
rotor (Beckman Coulter) and the resuspended pellet in PBS was
applied on top. The gradient was centrifuged for 17 h at 35,000 rpm
at 4 1C. Gradient fractions were collected from the top and their
density was determined by refractometry. Aliquots from each fraction
were used for the PERT assay.
Electron microscopy
Virus particles from the culture medium of infected cells were
pelleted by ultracentrifugation as described above and ﬁxed in 2%
formaldehyde. Samples negatively stained with 3% phosphotungs-
tic acid (PTA) were then viewed with Jeol JEM, 2000 CX micro-
scope (JEOL, Arishima, Japan).
Plasmid construction
For the preparation of replication-competent CrERV DNA clone,
two partially overlapping proviral fragments were separately ampli-
ﬁed from infected HEK-293 T cells using PCR. Primers for ampliﬁca-
tion of 50 CrERV fragment were: 50–AACCGCGGCCGCTGTAGGGA-
GAACAAACGGAATGTAGAAAG-30 (NotI restriction site used for clon-
ing is underlined ) and 50–CAGGGGTAGGCTGAAAAAGGCATC-30.
Primers for ampliﬁcation of 30 CrERV fragment were: 50–TACCCA-
TATGTGTTATGCCCGATGTCCGAATCC-30 (NdeI restriction site used
for cloning is underlined) and 50–GCCCTCAGAGGTCATAGCACCAGA-
30. Ampliﬁed DNA fragments covered the entire proviral sequence
and contained unique EcoRI restriction site in the overlapping
region. The DNA fragments were digested with NotI/EcoRI and
NdeI/EcoRI for the 50 and 30 regions, respectively. Consequently,
both cleaved fragments were sequentially ligated into the pGem-T
Easy cloning vector (Promega, Madison, WI), creating intact CrERV
proviral DNA clone (pCrERV-IND). To create the modiﬁed variant of
CrERV (CrERV-mut), 298 bp-long region of viral pol gene was PCR-
ampliﬁed using mutagenic primers which contain several mis-
matching bases and EcoRI/HpaI restriction sites naturally occurring
in viral sequence: 50–CCGGAATTCTTCGTCGGTGCCAA and 50–
CAAGTTAACTGCACCACAGGTTGG. Original sequence in pCrERV-
IND plasmid was replaced by this mutated fragment using EcoRI
and HpaI enzymes, which generated the pCrERV-mut construct.
Virus preparation and cell infection
HEK-293 T cells were transfected with pCrERV-IND or pCrERV-
mut plasmids using X-tremeGENE HP DNA Transfection Reagent
(Roche s.r.o., Prague, Czech Republic). Speciﬁcally, 5104 cells
were seeded onto 24-well plate and next day transfected by
addition of 100 μl of culture medium containing 0.5 μg of DNA
and 0.5 μl of the transfection reagent. Cells were grown for
approximately 30 days until the viral DNA copy number reached
plateau. Afterwards, 100 μl of ﬁltered cell supernatant was used for
infection of naïve HEK-293 T cells seeded on 24-well plate (5104
per well) a day before. After 1 h of incubation at 37 1C, 400 μl of
fresh medium was added, and the cells were further incubated in
CO2 at 37 1C. For determining the infectious titer of CrERV, 10-fold
dilutions of virus were inoculated in triplicate wells. The cells were
passaged for 4 weeks to allow virus spread, and scored for virus
presence using both PCR assays and PERT assay.
PCR-based detection of viral DNA (qPCR, digital droplet PCR and
standard analytical PCR)
For the determination of reversely-transcribed viral DNA,
infected cells were harvested at appropriate time points, washed
by PBS, and incubated in lysis buffer (10 mM Tris–HCl, pH 8.0, 1 mM
EDTA, 0.2 mM CaCl2, 0.001% Triton X-100, 0.001% SDS, 1 mg/ml
proteinase K) for 60 min at 58 1C, followed by 10 min prot-
ease heat-inactivation at 95 1C. Primers for quantitative PCR
(50–TGACCCCATGTTTGAATGTG and 50–GAGGACAGCTCCTTGGT-
TTG) were designed to conserved region of CrERV env gene using
Primer3Plus software (Untergasser et al., 2007). For the quantiﬁca-
tion of PERV DNA, primers 50–AGGTGGTGGGCATGTAATACTG and 50–
ACACTCGGGGAACAATTTGG, also situated in env gene, were used.
MESA GREEN qPCR mastermix (Eurogentec, Seraing, Belgium) was
used for standard real-time quantitative PCR. Each reaction mixture
had a total volume of 20 μl, containing 2 μl of the cell lysate and
300 nM (each) the forward and reverse primers. The samples were
run on a Bio-Rad CFX96™ Real-Time System (Bio-Rad, Hercules, CA)
with a two-step protocol (1 cycle of 5 min at 95 1C and then 44
cycles consisting of 15 s at 95 1C and 60 s at 60 1C), followed by
melting curve analysis in the CFX Manager software (Bio-Rad) to
ensure the speciﬁcity of the ampliﬁcation. An absolute standard
curve for each assay was obtained by using as templates serial
dilutions of a plasmid containing the corresponding amplicon. The
results were normalized using the parallel ampliﬁcation of a single-
copy genomic locus in porphobilinogen deaminase gene (Konig
et al., 2008).
For highly accurate absolute quantiﬁcation of viral DNA, droplet
digital PCR system QX200 (Bio-Rad, Hercules, CA) was used. Each
reaction mixture had a total volume of 20 μl, containing 1x QX200
ddPCR Evagreen Supermix (Bio-Rad), 2 μl of the cell lysate (1–5 ng
DNA), and 250 nM (each) the forward and reverse primers. The
reactions were treated for droplet generation according to the
manufacturer0s manual and then ampliﬁed with the following con-
ditions: 1 cycle of 5 min at 95 1C and then 40 cycles consisting of 15 s
at 95 1C and 40 s at 59 1C followed by 1 cycle of 5 min at 72 1C, 5 min
at 4 1C and 5min at 90 1C. Samples were analyzed by droplet reader
and QuantaSoft software (Bio-Rad) with thresholds set manually.
For speciﬁc detection of modiﬁed CrERV variant (CrERV-mut) in
infected cells, PCR primers complementary to the modiﬁed region
of viral DNA were designed: 50–GGATGCCGGAATTCTTCGT and 50–
GTCCAAGTTAACTGCACCACA. Primers complementary to the wild-
type CrERV sequence were used as a positive control: 50–GGA-
TGCCGGAATTCTCAGG-30 and 50–GGGTCCAAGTTAACTGTACTA-
CC-30. OneTaq mastermix (New England Biolabs, Ipswich, MA)
was used for analytic PCR ampliﬁcation. Each reaction mixture had
a total volume of 20 μl, containing 2 μl of the cell lysate and
200 nM (each) the forward and reverse primers. The samples were
run with a following protocol: 1 cycle of 3 min at 94 1C and then
32 cycles consisting of 20 s at 94 1C, 30 s at 60 1C and 30 s at 68 1C
ﬁnished by 1 cycle of 5 min at 68 1C and analyzed by agarose gel
electrophoresis.
Phylogenetic tree
The 30 portion of 13 CrERV sequences (approximately 1100 bp)
was aligned using Muscle (Edgar, 2004) and the phylogeny was
generated with PhyML (Guindon et al., 2010) and the HKY85
model with a gamma distribution.
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